CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −12,000 | $10.08 | $121K | 84,694 |
| 2026-02-13 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −4,701 | $7.78 | $37K | 96,694 |
| 2026-01-14 | Moran Sean F. Chief Financial Officer | Grant or award | +28,082 | 101,395 | ||
| 2026-01-14 | Moran Sean F. Chief Financial Officer | Grant or award · Stock options (right to buy) | +84,247 | 84,247 | ||
| 2025-10-24 | Moran Sean F. Chief Financial Officer | Exercise or conversion 10b5-1 | +12,981 | $4.26 | $55K | 86,294 |
| 2025-10-24 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −12,981 | $17.02 | $221K | 73,313 |
| 2025-10-24 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Stock options (right to buy) 10b5-1 | −12,981 | 10,386 | ||
| 2025-02-14 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −2,792 | $8.76 | $24K | 73,313 |
| 2025-01-31 | Moran Sean F. Chief Financial Officer | Grant or award | +27,500 | 76,105 | ||
| 2025-01-31 | Moran Sean F. Chief Financial Officer | Grant or award · Stock options (right to buy) | +92,500 | 92,500 | ||
| 2024-06-18 | Moran Sean F. Chief Financial Officer | Exercise or conversion 10b5-1 | +1,958 | $30.00 | $59K | 50,563 |
| 2024-06-18 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −1,958 | $42.12 | $82K | 48,605 |
| 2024-06-18 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Options to purchase common stock 10b5-1 | −1,958 | 0 | ||
| 2024-06-17 | Moran Sean F. Chief Financial Officer | Exercise or conversion 10b5-1 | +6,730 | $14.10 | $95K | 55,335 |
| 2024-06-17 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −6,730 | $46.77 | $315K | 48,605 |
| 2024-06-17 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Options to purchase common stock 10b5-1 | −6,730 | 11,217 | ||
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Exercise or conversion 10b5-1 | +1,567 | $30.00 | $47K | 50,172 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −1,567 | $49.87 | $78K | 48,605 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Exercise or conversion 10b5-1 | +7,788 | $4.26 | $33K | 56,393 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −7,788 | $49.87 | $388K | 48,605 |
Page 1 of 3 · 53 trades